Eikonoklastes Therapeutics Closes Oversubscribed Seed Financing to Advance Next-Generation Tissue Factor (TF) Immunotherapies With Initial Focus on Triple-Negative Breast Cancer July 22, 2020

Published By :
July 21, 2020
email icon in blackFacebook icon in blacktwitter icon in blackLinkedIn icon in black
gradient colors in orange, pink and purple
Subscribe TO our newsletter

Stay Up To Date With Our News & Insights

Stay informed with current news about our portfolio companies, events and industry insights.
email icon in gradient orange, pink and purple colors
You are subscribed to our newsletters
Oops! Something went wrong while submitting the form.